苑东生物
(688513)
| 流通市值：80.13亿 | | | 总市值：80.13亿 |
| 流通股本：1.77亿 | | | 总股本：1.77亿 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 328,007,998.46 | 326,009,384.37 | 855,427,501.81 | 584,411,799.85 |
| 交易性金融资产 | 1,344,517,308.33 | 1,295,520,743.46 | 758,004,625.52 | 981,757,088.22 |
| 应收票据及应收账款 | 188,471,636.99 | 198,596,530.35 | 201,354,482.1 | 233,182,625.51 |
| 其中：应收票据 | 21,103,457.92 | 20,605,823.61 | 20,066,391.24 | 15,124,039.36 |
| 应收账款 | 167,368,179.07 | 177,990,706.74 | 181,288,090.86 | 218,058,586.15 |
| 应收款项融资 | 8,600,726.45 | 14,872,040.03 | 56,425,469.07 | 24,136,781.75 |
| 预付款项 | 18,395,941.09 | 16,962,564.54 | 18,303,828.66 | 17,440,341.18 |
| 其他应收款合计 | 515,158.19 | 438,179.08 | 314,711.62 | 532,223.15 |
| 存货 | 247,989,817.89 | 246,660,479.19 | 228,705,709.64 | 224,831,182.36 |
| 其他流动资产 | 25,546,800.37 | 18,314,362.65 | 13,627,964.14 | 8,877,124.47 |
| 流动资产合计 | 2,162,045,387.77 | 2,117,374,283.67 | 2,132,164,292.56 | 2,075,169,166.49 |
| 非流动资产: | | | | |
| 长期股权投资 | 22,818,512.27 | 22,855,926.86 | 23,212,698.29 | 51,548,771.23 |
| 其他非流动金融资产 | 54,000,000 | 54,000,000 | 48,000,000 | 48,000,000 |
| 固定资产 | 1,149,235,995.56 | 1,151,496,210.15 | 1,170,462,043.71 | 1,107,386,532.91 |
| 在建工程 | 69,954,079.6 | 61,078,928.94 | 53,737,809.31 | 118,497,314.07 |
| 无形资产 | 213,974,141.78 | 202,056,647.16 | 207,013,193.12 | 33,813,647.71 |
| 开发支出 | 85,213,828.69 | 96,581,042.12 | 94,209,256.72 | 85,169,414.74 |
| 商誉 | 23,099,384.34 | 23,099,384.34 | 23,099,384.34 | - |
| 长期待摊费用 | 4,239,118.34 | 4,484,491.21 | 4,963,359.49 | 4,314,672.9 |
| 递延所得税资产 | 18,698,810.67 | 25,483,933.38 | 23,676,080.3 | 12,855,577.91 |
| 其他非流动资产 | 20,899,609.1 | 18,933,705.73 | 17,341,189.37 | 22,166,935.14 |
| 非流动资产合计 | 1,662,133,480.35 | 1,660,070,269.89 | 1,665,715,014.65 | 1,483,752,866.61 |
| 资产总计 | 3,824,178,868.12 | 3,777,444,553.56 | 3,797,879,307.21 | 3,558,922,033.1 |
| 流动负债: | | | | |
| 短期借款 | 115,012,415.7 | 45,379,472.07 | 110,713,599.13 | 95,075,403.53 |
| 应付票据及应付账款 | 134,158,523.11 | 105,025,049.68 | 124,980,394.29 | 141,912,016.38 |
| 其中：应付票据 | 44,051,381.39 | 34,341,148.81 | 41,586,301.91 | 38,826,377.01 |
| 应付账款 | 90,107,141.72 | 70,683,900.87 | 83,394,092.38 | 103,085,639.37 |
| 合同负债 | 33,166,178.24 | 27,886,774.38 | 23,307,632.19 | 27,659,994.31 |
| 应付职工薪酬 | 31,946,530.53 | 26,241,680.17 | 49,407,102 | 37,607,660.5 |
| 应交税费 | 33,864,025.07 | 29,370,205.3 | 30,580,175.97 | 37,935,825.01 |
| 其他应付款合计 | 308,340,557.89 | 309,815,584.65 | 270,272,142.26 | 241,035,125.72 |
| 一年内到期的非流动负债 | 4,400,000 | 4,400,000 | 4,400,000 | 4,400,000 |
| 其他流动负债 | 4,777,791.19 | 5,519,458.72 | 5,035,679.6 | 7,641,317.23 |
| 流动负债合计 | 665,666,021.73 | 553,638,224.97 | 618,696,725.44 | 593,267,342.68 |
| 非流动负债: | | | | |
| 长期借款 | 29,333,333.32 | 31,555,292.58 | 31,533,333.32 | 33,754,518.51 |
| 递延收益 | 63,158,777.79 | 60,825,820.26 | 62,487,374.29 | 63,021,750.1 |
| 递延所得税负债 | 44,260,612.72 | 45,468,032.47 | 46,186,366.18 | 2,897,360.11 |
| 非流动负债合计 | 136,752,723.83 | 137,849,145.31 | 140,207,073.79 | 99,673,628.72 |
| 负债合计 | 802,418,745.56 | 691,487,370.28 | 758,903,799.23 | 692,940,971.4 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 176,532,256 | 176,532,256 | 176,532,256 | 176,532,256 |
| 资本公积 | 1,394,854,699.02 | 1,406,888,704.83 | 1,403,665,010.02 | 1,399,773,459.84 |
| 减:库存股 | 103,449,813.76 | 67,672,535.14 | 67,672,535.14 | 67,672,535.14 |
| 专项储备 | 1,960,628.18 | 1,735,314.62 | 1,259,100.45 | 2,190,411.55 |
| 盈余公积 | 88,266,128 | 88,266,128 | 88,266,128 | 79,462,430.94 |
| 未分配利润 | 1,375,107,223.9 | 1,381,619,264.85 | 1,330,788,242.97 | 1,275,695,038.51 |
| 归属于母公司股东权益合计 | 2,933,271,121.34 | 2,987,369,133.16 | 2,932,838,202.3 | 2,865,981,061.7 |
| 少数股东权益 | 88,489,001.22 | 98,588,050.12 | 106,137,305.68 | - |
| 股东权益合计 | 3,021,760,122.56 | 3,085,957,183.28 | 3,038,975,507.98 | 2,865,981,061.7 |
| 负债和股东权益合计 | 3,824,178,868.12 | 3,777,444,553.56 | 3,797,879,307.21 | 3,558,922,033.1 |
| 公告日期 | 2026-08-21 | 2026-04-22 | 2026-04-22 | 2025-10-28 |
| 审计意见(境内) | | | 标准无保留意见 | |